The Max Planck Institute for Innovation and Competition in Munich is making a scientific contribution to economic reconstruction of Ukraine with its project “From Legacy to Leadership” funded by the Volkswagen Foundation. It aims to develope a playbook to rebuild Ukraine’s pharmaceutical industry in partnership with the EU. This will enable the country’s heritage and expertise to be used to strengthen EU supply chains and boost Ukraine’s economy.
In the Volksvagen Foundation’s news feature “A new beginning for the Ukrainian pharmaceutical industry” it is stated: “Despite the major challenges, there is positive potential in the historical heritage of the Ukrainian pharmaceutical industry from the Soviet era: over 70% of the Soviet Union’s total R&D and production capacity in the pharmaceutical sector was located in Ukraine. The German-Ukrainian project team now aims to use this ‘industrial memory’ to lay the foundations for an innovative and stable industry. This should not only contribute to stabilising the Ukrainian economy, but also improve the supply of medicines in Europe. In times of global uncertainty – whether due to pandemics or geopolitical tensions – this would be a valuable contribution to diversification and resilience.”
The Max Planck Institute for Innovation and Competition cooperates with the Academic Department of International, Civil, and Commercial Law at the State University of Trade and Economics, Ukraine and the Business Economics and Entrepreneurship Department at Kyiv National Economic University named after Vadym Hetman.